CrossRef Cited By Search Results

This article [doi:10.1054/bjoc.2000.1307] has been cited in the following papers, taken from those publishers and societies that are participating in CrossRef's Cited-by Linking service. The number of citations from this service is usually lower than citation numbers from databases that include more journals.

BACK TO ARTICLE

  1. ISSN: 10781641

    Current Opinion in Pulmonary Medicine

    The role of palliative care in the lung cancer patient: can we improve quality while limiting futile care?

    Orit C Freedman, Camilla Zimmermann

    15 (4), 2009, p.321

    doi:10.1097/MCP.0b013e32832b8a5d

  2. EISSN: 17448336 ISSN: 14787210

    Expert Review of Anticancer Therapy

    Paclitaxel poliglumex (PPX, CT-2103): macromolecular medicine for advanced non-small-cell lung cancer

    Philip Bonomi

    7 (4), 2007, p.415

    doi:10.1586/14737140.7.4.415

  3. EISSN: 14653621 ISSN: 03682811

    Japanese Journal of Clinical Oncology

    A Phase I Study of Gemcitabine and Carboplatin in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2

    Y. H. Kim et al.

    39 (9), 2009, p.576

    doi:10.1093/jjco/hyp061

  4. EISSN: 15730646 ISSN: 01676997

    Investigational New Drugs

    Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study

    Emilio Esteban et al.

    26 (1), 2008, p.67

    doi:10.1007/s10637-007-9073-4

  5. EISSN: 13652354 ISSN: 09615423

    European Journal of Cancer Care

    Best supportive care in lung cancer trials is inadequately described: a systematic review

    B. JACK, A. BOLAND, R. DICKSON, J. STEVENSON, C. MCLEOD

    doi:10.1111/j.1365-2354.2008.01064.x

  6. ISSN: 10408746

    Current Opinion in Oncology

    Richard Booton, Nicholas Thatcher

    14 (2), 2002, p.191

    doi:10.1097/00001622-200203000-00009

  7. ISSN: 10408746

    Current Opinion in Oncology

    George Dranitsaris, Wayne Cottrell, William Evans

    14 (4), 2002, p.375

    doi:10.1097/00001622-200207000-00001

  8. ISSN: 10408746

    Current Opinion in Oncology

    Louise Medley, Michael Cullen

    14 (4), 2002, p.384

    doi:10.1097/00001622-200207000-00002

  9. ISSN: 10408746

    Current Opinion in Oncology

    Marianne Paesmans

    14 (4), 2002, p.389

    doi:10.1097/00001622-200207000-00003

  10. EISSN: 14330415 ISSN: 09478965

    Der Onkologe

    Symptomkontrollierende Effekte der Chemotherapie

    B. Alt-Epping, W. Jung, F. Nauck

    13 (7), 2007, p.619

    doi:10.1007/s00761-007-1215-y

  11. EISSN: 16993055 ISSN: 1699048X

    Clinical and Translational Oncology

    Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis

    César Mendiola, M. Ángeles Vaz

    11 (8), 2009, p.554

    doi:10.1007/s12094-009-0403-1

  12. ISSN: 10680640

    Clinical Pulmonary Medicine

    Nonplatinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer

    Tony S. K. Mok, Anthony T. C. Chan

    10 (3), 2003, p.143

    doi:10.1097/01.cpm.0000059369.04504.d5

  13. ISSN: 11756357

    American Journal of Cancer

    Treatment of Patients with Advanced Non-Small Cell Lung Cancer

    Christophe A Dooms, Johan F Vansteenkiste

    3 (5), 2004, p.281

    doi:10.2165/00024669-200403050-00002

  14. EISSN: 17448379 ISSN: 14737167

    Expert Review of Pharmacoeconomics & Outcomes Research

    Is gemcitabine cost effective in cancer treatment?

    Luca Toschi et al.

    7 (3), 2007, p.239

    doi:10.1586/14737167.7.3.239

  15. EISSN: 17448301 ISSN: 14796694

    Future Oncology

    Role of gemcitabine in cancer therapy

    L Toschi, G Finocchiaro, S Bartolini, V Gioia, F Cappuzzo

    1 (1), 2005, p.7

    doi:10.1517/14796694.1.1.7

  16. ISSN: 11707690

    PharmacoEconomics

    Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

    Sabrina Trippoli, Monica Vaiani, Carlo Lucioni, Andrea Messori

    19 (8), 2001, p.855

    doi:10.2165/00019053-200119080-00007

  17. ISSN: 02773732

    American Journal of Clinical Oncology

    Phase I Study of Fixed Dose Gemcitabine Plus Epirubicin in Patients With Advanced Solid Malignancies :

    Daruka Mahadevan et al.

    32 (6), 2009, p.607

    doi:10.1097/COC.0b013e31819cc9ed

  18. EISSN: 15346277 ISSN: 15272729

    Current Treatment Options in Oncology

    Solitary sites of metastatic disease in non-small cell lung cancer

    Matthew J. Schuchert, James D. Luketich

    4 (1), 2003, p.65

    doi:10.1007/s11864-003-0033-8

  19. EISSN: 18634362 ISSN: 00211265

    Irish Journal of Medical Science

    Combination chemotherapy in the treatment of inoperable non-small cell lung cancer

    R. M. Rutherford, T. Azher, J. J. Gilmartin

    171 (4), 2002, p.193

    doi:10.1007/BF03170278

  20. EISSN: 17448336 ISSN: 14787210

    Expert Review of Anticancer Therapy

    Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?

    Antonio Saha, Robin Rudd

    6 (2), 2006, p.165

    doi:10.1586/14737140.6.2.165

  21. EISSN: 15321827 ISSN: 00070920

    British Journal of Cancer

    Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer

    T Kurata et al.

    doi:10.1038/sj.bjc.6601817

  22. EISSN: 15321827 ISSN: 00070920

    British Journal of Cancer

    Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

    P Comella et al.

    91 (3), 2004, p.489

    doi:10.1038/sj.bjc.6602011

  23. EISSN: 10970142 ISSN: 0008543X

    Cancer

    Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma

    Sarah Danson et al.

    98 (3), 2003, p.542

    doi:10.1002/cncr.11535

  24. EISSN: 10982388 ISSN: 87560437

    Seminars in Surgical Oncology

    Chemotherapy in metastatic and locally advanced non-small cell lung cancer

    David R. Spigel, F. Anthony Greco

    21 (2), 2003, p.98

    doi:10.1002/ssu.10027

  25. EISSN: 10982388 ISSN: 87560437

    Seminars in Surgical Oncology

    Palliative therapy for lung cancer

    Andrea Bezjak

    21 (2), 2003, p.138

    doi:10.1002/ssu.10031

  26. EISSN: 10970142 ISSN: 0008543X

    Cancer

    Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

    Jeffrey Crawford et al.

    95 (4), 2002, p.888

    doi:10.1002/cncr.10763

  27. EISSN: 10970142 ISSN: 0008543X

    Cancer

    Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594

    Christopher J. Sweeney et al.

    92 (10), 2001, p.2639

    doi:10.1002/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8

  28. EISSN: 10970142 ISSN: 0008543X

    Cancer

    Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens

    Christos Kosmas et al.

    92 (11), 2001, p.2902

    doi:10.1002/1097-0142(20011201)92:11<2902::AID-CNCR10103>3.0.CO;2-O

  29. EISSN: 17448336 ISSN: 14787210

    Expert Review of Anticancer Therapy

    The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer

    Christophe A Dooms, Karin E Pat, Johan F Vansteenkiste

    6 (4), 2006, p.531

    doi:10.1586/14737140.6.4.531

  30. EISSN: 15321827 ISSN: 00070920

    British Journal of Cancer

    A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment

    F M Wachters et al.

    92 (1), 2005, p.15

    doi:10.1038/sj.bjc.6602268

  31. EISSN: 15321827 ISSN: 00070920

    British Journal of Cancer

    The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE)

    J S Waters, M E R O'Brien

    87 (5), 2002, p.481

    doi:10.1038/sj.bjc.6600491

  32. EISSN: 15321827 ISSN: 00070920

    British Journal of Cancer

    Platinum drugs in the treatment of non-small-cell lung cancer

    J Cosaert, E Quoix

    87 (8), 2002, p.825

    doi:10.1038/sj.bjc.6600540

  33. EISSN: 15321827 ISSN: 00070920

    British Journal of Cancer

    A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC

    M Michael et al.

    93 (6), 2005, p.652

    doi:10.1038/sj.bjc.6602759

  34. ISSN: 02773732

    American Journal of Clinical Oncology

    Gemcitabine, Ifosfamide, and Cisplatin Combination (GIP) in Treatment of Patients With Locally Advanced or Metastatic Nonsmall Cell Lung Cancer

    David Planchard et al.

    29 (4), 2006, p.345

    doi:10.1097/01.coc.0000221320.81753.a9

  35. EISSN: 14320843 ISSN: 03445704

    Cancer Chemotherapy and Pharmacology

    Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma

    J. Castro et al.

    55 (2), 2005, p.197

    doi:10.1007/s00280-004-0869-z

  36. EISSN: 10970142 ISSN: 0008543X

    Cancer

    Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma

    Ji-Youn Han et al.

    104 (12), 2005, p.2759

    doi:10.1002/cncr.21563

  37. ISSN: 11756357

    American Journal of Cancer

    Role of Non-Taxane-Containing Chemotherapy in Advanced Non-Small Cell Lung Cancer

    Michael Bergqvist, Sverre S??renson, Daniel Brattstr??m, Tony Mok, Roger Henriksson

    5 (4), 2006, p.223

    doi:10.2165/00024669-200605040-00003

  38. EISSN: 17421241 ISSN: 13685031

    International Journal of Clinical Practice

    The management of PS2 patients with advanced non-small cell lung cancer

    K. A. CHEONG, K. CHRYSTAL, P. G. HARPER

    60 (11), 2006, p.1493

    doi:10.1111/j.1742-1241.2006.00878.x

  39. EISSN: 15321827 ISSN: 00070920

    British Journal of Cancer

    Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

    S Sorenson et al.

    95 (8), 2006, p.966

    doi:10.1038/sj.bjc.6603383

  40. EISSN: 17448379 ISSN: 14737167

    Expert Review of Pharmacoeconomics & Outcomes Research

    Quality of life issues in non-small cell lung cancer

    Richard Stephens

    4 (2), 2004, p.215

    doi:10.1586/14737167.4.2.215

  41. ISSN: 02773732

    American Journal of Clinical Oncology

    Phase I Study With Dose Escalation of Gemcitabine and Cisplatin in Combination With Ifosfamide (GIP) in Patients With Non???Small-Cell Lung Carcinoma

    Hugues Bourgeois et al.

    27 (1), 2004, p.89

    doi:10.1097/01.coc.0000046580.51486.FF

  42. EISSN: 10970142 ISSN: 0008543X

    Cancer

    Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC)

    Vera Hirsh et al.

    97 (9), 2003, p.2242

    doi:10.1002/cncr.11319

  43. EISSN: 17447666 ISSN: 14656566

    Expert Opinion on Pharmacotherapy

    Combination therapy versus single agent chemotherapy in non-small cell lung cancer

    Kerry Cheong, James Spicer, Simon Chowdhury, Peter Harper

    6 (10), 2005, p.1693

    doi:10.1517/14656566.6.10.1693

  44. EISSN: 58474714 ISSN: 14712598

    Expert Opinion on Biological Therapy

    Cetuximab in non-small cell lung cancer

    Foluso O Ademuyiwa, Nasser Hanna

    8 (1), 2008, p.107

    doi:10.1517/14712598.8.1.107

  45. ISSN: 15560864

    Journal of Thoracic Oncology

    Third-Generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: A Meta-Analysis

    Maria Q. Baggstrom et al.

    2 (9), 2007, p.845

    doi:10.1097/JTO.0b013e31814617a2

  46. ISSN: 15560864

    Journal of Thoracic Oncology

    A Randomized Phase II Trial of Single-Agent Gemcitabine, Vinorelbine, or Docetaxel in Patients with Advanced Non-small Cell Lung Cancer Who Have Poor Performance Status and/or Are Elderly

    Swan Swan Leong et al.

    2 (3), 2007, p.230

    doi:10.1097/JTO.0b013e318031d06f

  47. ISSN: 15560864

    Journal of Thoracic Oncology

    DHA-Paclitaxel (Taxoprexin) as First-Line Treatment in Patients with Stage IIIB or IV Non-small Cell Lung Cancer: Report of a Phase II Open-Label Multicenter Trial

    Miranda Payne et al.

    1 (9), 2006, p.984

    doi:10.1097/01243894-200611000-00011

  48. ISSN: 15560864

    Journal of Thoracic Oncology

    Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

    Paul J. Hesketh et al.

    1 (6), 2006, p.537

    doi:10.1097/01243894-200607000-00007

  49. EISSN: 15244741 ISSN: 1075122X

    The Breast Journal

    Clinical Interpretation of Quality-of-Life Outcomes: An Investigation of Data from the Randomized Trial of Gemcitabine Plus Paclitaxel Compared with Paclitaxel Alone for Advanced Breast Cancer

    Penelope Hopwood, Jessamy Watkins, Paul Ellis, Ian Smith

    14 (3), 2008, p.228

    doi:10.1111/j.1524-4741.2008.00567.x

  50. EISSN: 10970142 ISSN: 0008543X

    Cancer

    Aggressiveness of care in a prospective cohort of patients with advanced NSCLC

    Jennifer S. Temel et al.

    113 (4), 2008, p.826

    doi:10.1002/cncr.23620

  51. EISSN: 17447666 ISSN: 14656566

    Expert Opinion on Pharmacotherapy

    Gemcitabine in non-small cell lung cancer

    Federico Cappuzzo, Lucio Crinò

    3 (6), 2002, p.745

    doi:10.1517/14656566.3.6.745

  52. EISSN: 17447666 ISSN: 14656566

    Expert Opinion on Pharmacotherapy

    Assessing outcomes in palliative chemotherapy

    Emma Cattell, Ana Arance, Mark Middleton

    3 (6), 2002, p.693

    doi:10.1517/14656566.3.6.693

  53. ISSN: 1170229X

    Drugs & Aging

    Quality-of-Life Assessment in Phase III Clinical Trials of Gemcitabine in Non-Small-Cell Lung Cancer

    Jonathan K Reynolds, Terri L Levien

    25 (11), 2008, p.893

    doi:10.2165/0002512-200825110-00001

  54. EISSN: 17437563 ISSN: 17437555

    Asia-Pacific Journal of Clinical Oncology

    Gemcitabine-induced radiation recall in the treatment of pancreatic cancer

    Wan Mohd Nazri WAN ZAINON et al.

    5 (1), 2009, p.17

    doi:10.1111/j.1743-7563.2009.01187.x

BACK TO ARTICLE